Home LiteratureArticle Details
PMID: 9108309 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

RNA polymerase III interferes with Ty3 integration.

FEBS letters ·Vol. 405 ·No. 3 ·1997-04-01 ·Pages 305-11

Connolly CM, Sandmeyer SB

Abstract

Ty3, a gypsylike retrotransposon of budding yeast, integrates at the transcription initiation site of genes transcribed by RNA polymerase III (pol III). It was previously shown that integration in vitro requires intact promoter elements and the pol III transcription factors TFIIIB and TFIIIC. In order to test the effect of pol III on integration, increasing amounts of a pol III-containing fraction were added to Ty3 in vitro integration reactions. The pol III-containing fraction was inhibitory to integration. These results are consistent with a model where the Ty3 integration complex and pol III recognize similar features of the stable transcription complex and compete with each other for access to the transcription initiation site.

MeSH Terms
RNA Polymerase III/metabolism RNA, Transfer/genetics RNA-Binding Proteins/metabolism Retroelements/genetics Saccharomyces cerevisiae/genetics Transcription, Genetic Virus Integration
Chemicals
RNA-Binding Proteins Retroelements RNA, Transfer RNA Polymerase III
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Connolly C M
Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine 92697-4025, USA.
Sandmeyer S B
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1997-04-01
Pages
305-11
Language
English
Region
England
NLM ID
0155157
Subset
IM
Grants
NIGMS NIH HHS · GM33281 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]